{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:38:33Z","timestamp":1783485513971,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jaad.2020.05.081","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T11:42:15Z","timestamp":1590061335000},"page":"1021-1027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Spironolactone use does not increase the risk of female breast cancer recurrence: A retrospective analysis"],"prefix":"10.1016","volume":"83","author":[{"given":"Chapman","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patawut","family":"Bovonratwet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaby","family":"Moawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2020.05.081_bib1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.det.2010.03.011","article-title":"Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss","volume":"28","author":"Rathnayake","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2020.05.081_bib2","first-page":"541","article-title":"Female pattern alopecia: current perspectives","volume":"5","author":"Levy","year":"2013","journal-title":"Int J Womens Health"},{"issue":"3","key":"10.1016\/j.jaad.2020.05.081_bib3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/bcp.13152","article-title":"Spironolactone use and risk of incident cancers: a retrospective, matched cohort study","volume":"83","author":"Mackenzie","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"5, Supplement 1","key":"10.1016\/j.jaad.2020.05.081_bib4","first-page":"AB72","article-title":"Spironolactone use and the risk of breast cancer","volume":"24","author":"Almukhtar","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.05.081_bib5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.canep.2013.10.004","article-title":"Spironolactone use and the risk of breast and gynecologic cancers","volume":"37","author":"Biggar","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.jaad.2020.05.081_bib6","author":"World Health Organization"},{"issue":"1","key":"10.1016\/j.jaad.2020.05.081_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10549-018-4996-3","article-title":"Safety of 5\u03b1-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies","volume":"174","author":"Rozner","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jaad.2020.05.081_bib8","doi-asserted-by":"crossref","first-page":"e4447","DOI":"10.1136\/bmj.e4447","article-title":"Spironolactone and the risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study","volume":"345","author":"Mackenzie","year":"2012","journal-title":"BMJ"},{"issue":"19","key":"10.1016\/j.jaad.2020.05.081_bib9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1200\/JCO.2015.62.3504","article-title":"Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the International Breast Cancer Study Group Trials I to V","volume":"34","author":"Colleoni","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2020.05.081_bib10","first-page":"322","article-title":"Hormone replacement therapy: an increased risk of recurrence and mortality for breast cancer patients?","volume":"6","author":"Lupo","year":"2015","journal-title":"J Adv Pract Oncol"},{"key":"10.1016\/j.jaad.2020.05.081_bib11","author":"BlueCross BlueShield of Alabama"},{"key":"10.1016\/j.jaad.2020.05.081_bib12","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.12688\/f1000research.11887.1","article-title":"Spironolactone in cardiovascular disease: an expanding universe?","volume":"6","author":"Funder","year":"2017","journal-title":"F1000Res"},{"issue":"2","key":"10.1016\/j.jaad.2020.05.081_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijwd.2016.12.002","article-title":"Spironolactone for the treatment of acne in women, a retrospective study of 110 patients","volume":"3","author":"Charny","year":"2017","journal-title":"Int J Womens Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2020.05.081_bib14","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.jaad.2020.05.081_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G\u2217Power 3: a flexible\u00a0statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"issue":"5","key":"10.1016\/j.jaad.2020.05.081_bib16","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1634\/theoncologist.2017-0423","article-title":"Estrogen receptor-positive breast cancer: exploiting signaling pathways implicated in endocrine resistance","volume":"23","author":"Brufsky","year":"2018","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.jaad.2020.05.081_bib17","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/annonc\/mds095","article-title":"Permanent scalp alopecia\u00a0related to breast cancer chemotherapy by sequential\u00a0fluorouracil\/epirubicin\/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients","volume":"23","author":"Kluger","year":"2012","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.jaad.2020.05.081_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s12609-013-0114-z","article-title":"Alcohol intake and breast\u00a0cancer risk: weighing the overall evidence","volume":"5","author":"McDonald","year":"2013","journal-title":"Curr Breast Cancer Rep"},{"issue":"1","key":"10.1016\/j.jaad.2020.05.081_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/1055-9965.EPI-12-1022","article-title":"Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project","volume":"22","author":"Kwan","year":"2013","journal-title":"Cancer Epidemol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.jaad.2020.05.081_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4048\/jbc.2018.21.2.158","article-title":"Interactions between alcohol consumption and adjuvant hormone therapy in relation to breast cancer-free survival","volume":"21","author":"Kowalksi","year":"2018","journal-title":"J Breast Cancer"},{"issue":"3","key":"10.1016\/j.jaad.2020.05.081_bib21","doi-asserted-by":"crossref","first-page":"e010547","DOI":"10.1136\/bmjopen-2015-010547","article-title":"Validity of ICD-9-CM codes for breast, lung, and colorectal cancers in three Italian administrative healthcare databases: a diagnostic accuracy study protocol","volume":"6","author":"Abraha","year":"2016","journal-title":"BMJ Open"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220309506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220309506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:54:14Z","timestamp":1759272854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220309506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0190962220309506"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.05.081","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spironolactone use does not increase the risk of female breast cancer recurrence: A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.05.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}